Chemistry:Narnatumab
From HandWiki
Short description: Monoclonal antibody
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | MST1R (aka RON) |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6454H10026N1754O2020S44 |
Molar mass | 145922.10 g·mol−1 |
(what is this?) (verify) |
Narnatumab is a human monoclonal antibody designed for the treatment of cancer.[1] Clinical development was abandoned after phase I trials.[2][3]
Narnatumab was developed by ImClone Systems.
References
- ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/narnatumab.pdf.
- ↑ "Narnatumumab". AdisInsight. Springer Nature Switzerland AG. http://adisinsight.springer.com/drugs/800032136.
- ↑ "Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors". Investigational New Drugs 35 (4): 442–450. August 2017. doi:10.1007/s10637-016-0413-0. PMID 28161886.
Original source: https://en.wikipedia.org/wiki/Narnatumab.
Read more |